What is New In Our Community

Get access to our breaking news, company information, publications, and resources

Press Releases


Pillar Biosciences to Present at NYBIO | NYSE Life Science Company Showcase on December 14th

Natick, MA – December 7, 2023 – Pillar Biosciences is pleased to announce that Randy Pritchard, Chief Executive Officer, and Vincent Ricci, Chief Financial Officer, will be presenting at the NYBIO | NYSE Life Science Company Showcase on December 14th. This event, organized by NewYorkBIO in partnership with the New York Stock Exchange (NYSE), brings together New York’s financial community and life science-focused companies to highlight innovative solutions and treatments that are revolutionizing patient care. The showcase will take place at the New York Stock Exchange, providing a platform for emerging biotech and life science companies to present their groundbreaking …


Pillar Biosciences to Present New Scientific Data at Association for Molecular Pathology Annual Meeting

NATICK, Mass. – November 8, 2023 – (PR NEWSWIRE) – Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced the company and scientific collaborators …


Beckman Coulter Life Sciences and Pillar Biosciences Announce NGS Application Development Pipeline for the Biomek NGeniuS System

Assays Focus on Accelerating Cancer Research INDIANAPOLIS – November 6, 2023 – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues …


Pillar Biosciences Launches oncoReveal Core LBx, an NGS Kit to Enable Localized Liquid Biopsy-Based Tumor Profiling

Research Use Only (RUO) NGS Kit will provide a simple, automatable, industry-leading liquid biopsy workflow NATICK, Mass. – September 19, 2023 – (PR NEWSWIRE) – …


Pillar Biosciences Inc.

9 Strathmore Rd., Natick MA, 01760

Scroll to Top